From experiments in the lab, to clinical trials on living, breathing, people, to obtaining patents on products and ideas, the world of science inherently contains some risk. Deciding which risks are worth taking, and then taking them is the job of Dr. Scott Rocklage. Now a managing partner at 5AM Ventures, Dr. Rocklage has devoted his life to science.
Dr. Rocklage holds a Bachelor’s of Science degree in Chemistry from the University of California, Berkeley and a Ph.D. in Chemistry from the Massachusetts Institute of Technology. With these degrees, he worked in research and development before moving on to the administrative side of doing business. He has held the positions of President, Chairman, and CEO at several different companies, including Cubist Pharmaceuticals and Nycomed Salutar. He has been involved in pharmaceutical drug trials, and was instrumental in obtaining FDA approval on various pharmaceutical drugs. His research has also led to patents on his inventions, with more than 30 attributable to him and learn more about Scott.
5AM Ventures, where Dr. Rocklage is a managing partner is a venture capital company. This company invests in other companies that are involved in life sciences. 5AM Ventures is especially interested in life science companies that are taking on some of the greatest challenges in health care today. With a more proactive approach, Dr. Rocklage spends time researching and studying what’s new in the world of healthcare and working with entrepreneurs in this field that are developing their ideas. Since by definition, venture capital companies take risks, Dr. Rocklage also meets with other 5AM Ventures professionals to assure that the portfolio, or what 5AM Ventures is invested in, is sound. As with all managerial positions, some of his time is also spent in board meetings. With more than thirty years of experience, Dr. Rocklage has been a leader in science, and he continues to be on the leading edge of funding the future of science as it relates to medicine and healthcare and resume him.